Donor-Specific HLA Antibodies in a Cohort Comparing Everolimus With Cyclosporine After Kidney Transplantation

Summary of FDA Antibody-Mediated Rejection Workshop

(2011) P. Archdeacon et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Revisiting Traditional Risk Factors for Rejection and Graft Loss After Kidney Transplantation

(2011) T. B. Dunn et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Donor-Specific Antibodies Accelerate Arteriosclerosis after Kidney Transplantation

(2011) G. S. Hill et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial

(2011) Klemens Budde et al.   LANCET

Natural History of Proteinuria in Renal Transplant Recipients Developing De Novo Human Leukocyte Antigen Antibodies

(2011) James Fotheringham et al.   TRANSPLANTATION

Immunosuppression with Belatacept-Based, Corticosteroid-Avoiding Regimens in De Novo Kidney Transplant Recipients

(2010) R. Ferguson et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Banff ’09 Meeting Report: Antibody Mediated Graft Deterioration and Implementation of Banff Working Groups

(2010) B. Sis et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Preexisting Donor-Specific HLA Antibodies Predict Outcome in Kidney Transplantation

(2010) C. Lefaucheur et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial

(2010) Matthew R. Weir et al.   KIDNEY INTERNATIONAL

The 'blood group O problem' in kidney transplantation--time to change?

(2010) P. Glander et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Renal Function, Efficacy, and Safety of Sirolimus and Mycophenolate Mofetil After Short-Term Calcineurin Inhibitor-Based Quadruple Therapy in De Novo Renal Transplant Patients: One-Year Analysis of a Randomized Multicenter Trial

(2010) Markus Guba et al.   TRANSPLANTATION

Belatacept-Based Regimens Versus a Cyclosporine A-Based Regimen in Kidney Transplant Recipients: 2-Year Results From the BENEFIT and BENEFIT-EXT Studies

(2010) Christian P. Larsen et al.   TRANSPLANTATION

Can We Eliminate Both Calcineurin Inhibitors and Steroids?

(2010) Y. Lebranchu   TRANSPLANTATION PROCEEDINGS

De Novo Anti-HLA Antibodies in Renal Allograft Recipients: A Cross-Section Study

(2010) A.I. Sánchez-Fructuoso et al.   TRANSPLANTATION PROCEEDINGS

Reducing De Novo Donor-Specific Antibody Levels during Acute Rejection Diminishes Renal Allograft Loss

(2009) M. J. Everly et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Efficacy on Renal Function of Early Conversion from Cyclosporine to Sirolimus 3 Months After Renal Transplantation: Concept Study

(2009) Y. Lebranchu et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Outcome of Subclinical Antibody-Mediated Rejection in Kidney Transplant Recipients with Preformed Donor-Specific Antibodies

(2009) A. Loupy et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Anti-Human Leukocyte Antigen and Donor-Specific Antibodies Detected by Luminex Posttransplant Serve as Biomarkers for Chronic Rejection of Renal Allografts

(2009) Nils Lachmann et al.   TRANSPLANTATION

The Spectrum of Antibody-Mediated Renal Allograft Injury: Implications for Treatment

(2008) J. Gloor et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Transplant Glomerulopathy

(2008) F. G. Cosio et al.   AMERICAN JOURNAL OF TRANSPLANTATION